Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-08
DOI
10.1038/s41582-020-0385-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus‐associated illnesses
- (2020) Geoffrey J. Gorse et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
- (2020) Clark D Russell et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
- (2020) Timothy P. Sheahan et al. Nature Communications
- Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
- (2020) Yajing Fu et al. VIROLOGICA SINICA
- SARS Cov‐2 infection in a renal‐transplanted patient: A case report
- (2020) Elena Seminari et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Immunosuppression drug‐related and clinical manifestation of Coronavirus disease 2019: A therapeutical hypothesis
- (2020) Antonio Romanelli et al. AMERICAN JOURNAL OF TRANSPLANTATION
- SARS‐CoV ‐2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad
- (2020) Sandra Amor et al. ANNALS OF NEUROLOGY
- A potential role for integrins in host cell entry by SARS-CoV-2
- (2020) Christian JA Sigrist et al. ANTIVIRAL RESEARCH
- Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
- (2020) Yvan Jamilloux et al. AUTOIMMUNITY REVIEWS
- Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing
- (2020) Timothy M Rawson et al. CLINICAL INFECTIOUS DISEASES
- Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)
- (2020) Waleed Alhazzani et al. CRITICAL CARE MEDICINE
- Uneventful course in IBD patients during SARS-CoV-2 outbreak in northern Italy
- (2020) Lorenzo Norsa et al. GASTROENTEROLOGY
- A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia
- (2020) Isabella Quinti et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
- (2020) Tobias Herold et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review
- (2020) Chiara Minotti et al. JOURNAL OF INFECTION
- Co‐infection in SARS‐CoV‐2 infected Patients: Where Are Influenza Virus and Rhinovirus/Enterovirus?
- (2020) Michael D. Nowak et al. JOURNAL OF MEDICAL VIROLOGY
- Persistent viral RNA positivity during recovery period of a patient with SARS‐CoV‐2 infection
- (2020) Jian‐Rong Yang et al. JOURNAL OF MEDICAL VIROLOGY
- Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus ‐2 (SARS‐CoV‐2)
- (2020) Alberto Paniz‐Mondolfi et al. JOURNAL OF MEDICAL VIROLOGY
- Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2
- (2020) M. D. Willis et al. JOURNAL OF NEUROLOGY
- Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP)
- (2020) Helmut Butzkueven et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Reply: Potential role of Janus kinase inhibitors in COVID-19
- (2020) Maddalena Napolitano et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic
- (2020) Saiju Jacob et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- SARS-CoV-2 shedding and infectivity – Authors' reply
- (2020) Fei Zhou et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Management challenges for chronic dysimmune neuropathies during the COVID ‐19 pandemic
- (2020) Yusuf A. Rajabally et al. MUSCLE & NERVE
- COVID-19 and neuromuscular disorders
- (2020) Amanda C. Guidon et al. NEUROLOGY
- Spread of SARS-CoV-2 in the Icelandic Population
- (2020) Daniel F. Gudbjartsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
- (2020) Rebecca Haberman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glatiramer acetate immune modulates B-cell antigen presentation in treatment of MS
- (2020) Darius Häusler et al. Neurology-Neuroimmunology & Neuroinflammation
- COVID-19 and MS disease-modifying therapies
- (2020) Joseph R. Berger et al. Neurology-Neuroimmunology & Neuroinflammation
- Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!
- (2020) Alan A. Nguyen et al. CLINICAL IMMUNOLOGY
- The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
- (2020) Sara Mastaglio et al. CLINICAL IMMUNOLOGY
- Epidemiology and clinical features of COVID-19: A review of current literature
- (2020) Juan A. Siordia JOURNAL OF CLINICAL VIROLOGY
- Central nervous system manifestations of COVID-19: A systematic review
- (2020) Ali A. Asadi-Pooya et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Myasthenic crisis in COVID-19
- (2020) Fadi Delly et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- An Italian programme for COVID-19 infection in multiple sclerosis
- (2020) Maria Pia Sormani LANCET NEUROLOGY
- Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum
- (2020) C. Louapre et al. REVUE NEUROLOGIQUE
- Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis
- (2020) F.A. Klok et al. THROMBOSIS RESEARCH
- Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge
- (2020) Edgar Carnero Contentti et al. Multiple Sclerosis and Related Disorders
- COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach
- (2020) Giovanna Borriello et al. Multiple Sclerosis and Related Disorders
- B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran
- (2020) Farinaz Safavi et al. Multiple Sclerosis and Related Disorders
- COVID-19 in persons with multiple sclerosis treated with ocrelizumab – A pharmacovigilance case series
- (2020) Richard Hughes et al. Multiple Sclerosis and Related Disorders
- COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
- (2020) Giovanni Novi et al. Multiple Sclerosis and Related Disorders
- Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis
- (2019) Richard K. Burt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of dimethyl fumarate on lymphocytes in RRMS
- (2019) Devangi Mehta et al. NEUROLOGY
- Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
- (2019) Jacqueline Palace et al. BRAIN
- Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects
- (2019) Luisa Klotz et al. Science Translational Medicine
- Characterizing lymphocyte counts and infection rates with long-term teriflunomide treatment: Pooled analysis of clinical trials
- (2019) Giancarlo Comi et al. Multiple Sclerosis Journal
- Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial
- (2019) Giancarlo Comi et al. LANCET NEUROLOGY
- Immune reconstitution therapies: concepts for durable remission in multiple sclerosis
- (2019) Jan D. Lünemann et al. Nature Reviews Neurology
- Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
- (2019) Gustavo Luna et al. JAMA Neurology
- The 5-year Tysabri Global Observational Program in Safety (TYGRIS) study confirms the long-term safety profile of natalizumab treatment in multiple sclerosis
- (2019) John Foley et al. Multiple Sclerosis and Related Disorders
- Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab
- (2019) Heinz Wiendl et al. Neurology-Neuroimmunology & Neuroinflammation
- Alemtuzumab therapy changes immunoglobulin levels in peripheral blood and CSF
- (2019) Nora Möhn et al. Neurology-Neuroimmunology & Neuroinflammation
- Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
- (2018) Yaseen M. Arabi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy
- (2018) H. K. Olberg et al. EUROPEAN JOURNAL OF NEUROLOGY
- Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells
- (2018) Bryan Ceronie et al. JOURNAL OF NEUROLOGY
- Cladribine: mechanisms and mysteries in multiple sclerosis
- (2018) Benjamin Meir Jacobs et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
- (2018) Ludwig Kappos et al. LANCET
- Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis
- (2018) Amit Bar-Or et al. NEUROLOGY
- Incidence and risk of glucocorticoid-associated adverse effects in patients with rheumatoid arthritis
- (2018) Jessica C. Wilson et al. ARTHRITIS CARE & RESEARCH
- HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimod
- (2018) Maria Donata Benedetti et al. Multiple Sclerosis and Related Disorders
- Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques
- (2018) Joseph Prescott et al. Frontiers in Immunology
- Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapies
- (2018) Christoph Metze et al. CNS Neuroscience & Therapeutics
- Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study
- (2018) Jeffrey A Cohen et al. Multiple Sclerosis Journal
- Herpes simplex virus encephalitis temporally associated with dimethyl fumarate-induced lymphopenia in a multiple sclerosis patient
- (2018) Paola Perini et al. Multiple Sclerosis and Related Disorders
- Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study
- (2018) Sibyl Wray et al. Multiple Sclerosis Journal
- Reactivation of hepatitis B virus with immune-escape mutations after ocrelizumab treatment for multiple sclerosis
- (2018) Maria R Ciardi et al. Open Forum Infectious Diseases
- Two decades of glatiramer acetate: From initial discovery to the current development of generics
- (2017) Bianca Weinstock-Guttman et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Reconstitution of the peripheral immune repertoire following withdrawal of fingolimod
- (2017) Mahtab Ghadiri et al. Multiple Sclerosis Journal
- Cladribine — an old newcomer for pulsed immune reconstitution in MS
- (2017) Heinz Wiendl Nature Reviews Neurology
- Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
- (2017) Paolo A. Muraro et al. Nature Reviews Neurology
- Alemtuzumab CARE-MS I 5-year follow-up
- (2017) Eva Havrdova et al. NEUROLOGY
- Natalizumab-associated PML
- (2017) Nicholas Schwab et al. NEUROLOGY
- Alemtuzumab CARE-MS II 5-year follow-up
- (2017) Alasdair J. Coles et al. NEUROLOGY
- Cladribine to Treat Relapsing Forms of Multiple Sclerosis
- (2017) Gavin Giovannoni Neurotherapeutics
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case–control analysis
- (2017) Jessica C. Wilson et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication
- (2017) Andrea Bilger et al. Oncotarget
- Reconstitution of the peripheral immune repertoire following withdrawal of fingolimod
- (2017) Mahtab Ghadiri et al. Multiple Sclerosis Journal
- Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis
- (2016) Rui Li et al. JOURNAL OF IMMUNOLOGY
- Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial
- (2016) Jeffrey A Cohen et al. LANCET NEUROLOGY
- Virus-related Merkel cell carcinoma complicating fingolimod treatment for multiple sclerosis
- (2016) Heidi N. Beadnall et al. NEUROLOGY
- International consensus guidance for management of myasthenia gravis
- (2016) Donald B. Sanders et al. NEUROLOGY
- Infection Risk and Safety of Corticosteroid Use
- (2016) Jameel Youssef et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- BK Polyomavirus and the Transplanted Kidney
- (2016) Caroline Lamarche et al. TRANSPLANTATION
- Hepatitis C virus (HCV) reactivation during fingolimod treatment for relapsing and remitting multiple sclerosis
- (2016) Asako Tagawa et al. Multiple Sclerosis and Related Disorders
- Human autoimmune diseases: a comprehensive update
- (2015) Lifeng Wang et al. JOURNAL OF INTERNAL MEDICINE
- PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate
- (2015) Thorsten Rosenkranz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Varicella-Zoster Virus Infections in Patients Treated With Fingolimod
- (2015) Ann M. Arvin et al. JAMA Neurology
- Serious Infections Among Adult Medicaid Beneficiaries With Systemic Lupus Erythematosus and Lupus Nephritis
- (2015) Candace H. Feldman et al. Arthritis & Rheumatology
- Alemtuzumab for the treatment of multiple sclerosis
- (2015) Mark Willis et al. Therapeutics and Clinical Risk Management
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- (2014) Amit Bar-Or EXPERIMENTAL NEUROLOGY
- Reprogramming the immune repertoire with alemtuzumab in MS
- (2013) Heinz Wiendl et al. Nature Reviews Neurology
- From Immunosuppression to Immunomodulation: Current Principles and Future Strategies
- (2013) Jiri Kovarik PATHOBIOLOGY
- Prolonged respiratory viral shedding in transplant patients
- (2013) C.R.A. de Lima et al. Transplant Infectious Disease
- Successful treatment of acyclovir-resistant herpes simplex virus type 2 proctitis with leflunomide in an HIV-infected man
- (2012) Andrés F. Henao-Martínez et al. JOURNAL OF CLINICAL VIROLOGY
- Rituximab-induced hepatitis C virus reactivation in rheumatoid arthritis
- (2012) Ko-Ming Lin et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS)
- (2012) Niklas Schmedt et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Using and Reporting the Delphi Method for Selecting Healthcare Quality Indicators: A Systematic Review
- (2011) Rym Boulkedid et al. PLoS One
- The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases
- (2010) Nichola Cooper et al. BRITISH JOURNAL OF HAEMATOLOGY
- Innate immune response to viral infection
- (2008) Shohei Koyama et al. CYTOKINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More